These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21406197)

  • 1. Induction of the fibrinolytic system by cartilage extract mediates its antiangiogenic effect in mouse glioma.
    Simard B; Bouamrani A; Jourdes P; Pernod G; Dimitriadou V; Berger F
    Microvasc Res; 2011 Jul; 82(1):6-17. PubMed ID: 21406197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-type plasminogen activator has antiangiogenic properties without effect on tumor growth in a rat C6 glioma model.
    Solly F; Fish R; Simard B; Bolle N; Kruithof E; Polack B; Pernod G
    Cancer Gene Ther; 2008 Oct; 15(10):685-92. PubMed ID: 18535615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shark cartilage extract induces cytokines expression and release in endothelial cells and induces E-selectin, plasminogen and t-PA genes expression through an antioxidant-sensitive mechanism.
    Simard B; Ratel D; Dupré I; Pautre V; Berger F
    Cytokine; 2013 Jan; 61(1):104-11. PubMed ID: 23063000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice.
    Scappaticci FA; Smith R; Pathak A; Schloss D; Lum B; Cao Y; Johnson F; Engleman EG; Nolan GP
    Mol Ther; 2001 Feb; 3(2):186-96. PubMed ID: 11237675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression.
    Perri SR; Nalbantoglu J; Annabi B; Koty Z; Lejeune L; François M; Di Falco MR; Béliveau R; Galipeau J
    Cancer Res; 2005 Sep; 65(18):8359-65. PubMed ID: 16166313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic kringles derived from human plasminogen and apolipoprotein(a) inhibit fibrinolysis through a mechanism that requires a functional lysine-binding site.
    Ahn JH; Lee HJ; Lee EK; Yu HK; Lee TH; Yoon Y; Kim SJ; Kim JS
    Biol Chem; 2011 Apr; 392(4):347-56. PubMed ID: 21194375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiostatin suppresses malignant glioma growth in vivo.
    Kirsch M; Strasser J; Allende R; Bello L; Zhang J; Black PM
    Cancer Res; 1998 Oct; 58(20):4654-9. PubMed ID: 9788618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of simvastatin on cigarette smoke extract induced tissue-type plasminogen activator and plasminogen activator inhibitor-1 expression in human umbilical vein endothelial cells.
    Hu XY; Ma YH; Wang C; Yang YH
    Chin Med J (Engl); 2009 Oct; 122(19):2380-5. PubMed ID: 20079143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
    Kim CK; Joe YA; Lee SK; Kim EK; O E; Kim HK; Oh BJ; Hong SH; Hong YK
    Cancer Lett; 2010 Feb; 288(2):251-60. PubMed ID: 19664879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action.
    Sharma MR; Rothman V; Tuszynski GP; Sharma MC
    Exp Mol Pathol; 2006 Oct; 81(2):136-45. PubMed ID: 16643891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors.
    Folkins C; Man S; Xu P; Shaked Y; Hicklin DJ; Kerbel RS
    Cancer Res; 2007 Apr; 67(8):3560-4. PubMed ID: 17440065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor-1 (PAI-1) gene transfection inhibits the liver metastasis of pancreatic cancer by preventing angiogenesis.
    Inoue M; Sawada T; Uchima Y; Kimura K; Nishihara T; Tanaka H; Yashiro M; Yamada N; Ohira M; Hirakawa K
    Oncol Rep; 2005 Dec; 14(6):1445-51. PubMed ID: 16273237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo induction of antiangiogenic activity by plasminogen activators and captopril.
    Merchan JR; Chan B; Kale S; Schnipper LE; Sukhatme VP
    J Natl Cancer Inst; 2003 Mar; 95(5):388-99. PubMed ID: 12618504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoids induced t-PA synthesis by C6 glioma cells--role in tumoral haemorrhagic necrosis.
    Pernod G; Amalfitano G; Le Magueresse B; Berger F; Polack B; Kolodié L
    Thromb Haemost; 1996 Feb; 75(2):332-8. PubMed ID: 8815586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of angiogenesis-driven Kaposi's sarcoma tumor growth in nude mice by oral N-acetylcysteine.
    Albini A; Morini M; D'Agostini F; Ferrari N; Campelli F; Arena G; Noonan DM; Pesce C; De Flora S
    Cancer Res; 2001 Nov; 61(22):8171-8. PubMed ID: 11719447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA.
    Tanaka T; Cao Y; Folkman J; Fine HA
    Cancer Res; 1998 Aug; 58(15):3362-9. PubMed ID: 9699667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravital microscopy reveals novel antivascular and antitumor effects of endostatin delivered locally by alginate-encapsulated cells.
    Read TA; Farhadi M; Bjerkvig R; Olsen BR; Rokstad AM; Huszthy PC; Vajkoczy P
    Cancer Res; 2001 Sep; 61(18):6830-7. PubMed ID: 11559558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic efficacy of angiostatin against weakly- and highly-immunogenic 3LL tumors.
    Li M; Huang X; Zhu Z; Zhao Q; Wong M; Gorelik E
    In Vivo; 2002; 16(6):577-82. PubMed ID: 12494903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.